Gaoling Fund LP has bought 15,00,000 shares of Syngene International at Rs 515 on the BSE on November 23, 2017. However, Steadview Capital Mauritius has sold 19,50,000 shares of the company at Rs 516.92.
Syngene International is India’s largest Contract Research Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 436.55 |
| Indegene | 482.65 |
| CMS Info Systems | 317.60 |
| JITF Infralogistics | 331.25 |
| Sagility | 42.17 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: